Download Files:
Products Details
Product Description
– LDHA-IN-5 is a novel, potent, dual GO/LDHA inhibitor for primary hyperoxaluria.
Web ID
– HY-115875
Shipping
– Room temperature
Applications
– Metabolism-sugar/lipid metabolism
Molecular Formula
– C27H22FN7O6S3
References
– [1]Ding J, et al. Dual Glycolate Oxidase/Lactate Dehydrogenase A Inhibitors for Primary Hyperoxaluria. ACS Med Chem Lett. 2021 May 20;12(7):1116-1123.
CAS Number
– 2776148-90-2
Molecular Weight
– 655.70
SMILES
– NS(=O)(C1=CC=C(C=C1F)CC2=C(N(N=C2C3=CC(SC4=C(N=NN4)C(O)=O)=CC=C3)C5=NC(C(O)=O)=CS5)CC6CC6)=O
Clinical Information
– No Development Reported
Research Area
– Metabolic Disease
Solubility
– 10 mM in DMSO
Target
– Lactate Dehydrogenase
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
